Sign In

Irma Kerliu-Saliu

Medical Science Liaison at Allergan

Irma Kerliu-Saliu is a seasoned healthcare professional with significant experience in the pharmaceutical industry, particularly in Medical Affairs. She currently holds the position of National Director of Psychiatry Medical Science Liaisons for US Field Medical Affairs at AbbVie.12

In her role, Irma is responsible for leading a team of Medical Science Liaisons (MSLs) focused on psychiatry. Her work involves engaging with key opinion leaders (KOLs) and healthcare providers to facilitate scientific exchange and gather valuable insights that inform organizational strategy.13

Irma has contributed to the field of Medical Affairs through her involvement in developing guidance documents for Field Medical Metrics and Key Performance Indicators (KPIs). She collaborated with other industry experts to create resources that help measure and demonstrate the value of Field Medical teams within pharmaceutical organizations.13

Her expertise extends to areas such as KOL identification, influence measurement, and the strategic alignment of Field Medical activities with organizational objectives. Irma's work emphasizes the importance of both quantitative and qualitative metrics in evaluating the impact of Field Medical functions.3

With over a decade of experience in the healthcare industry, Irma Kerliu-Saliu has established herself as a leader capable of driving success in medical affairs and contributing to the broader goals of improving patient outcomes through scientific expertise and stakeholder engagement.4

Highlights

Feb 17 · medicalaffairs.org
Communicating the Value of Field Medical to Internal Stakeholders
Communicating the Value of Field Medical to Internal Stakeholders
Sep 26 · anjusoftware.com
Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
Atypical uterine leiomyoma: a case report and review of the literature
Atypical uterine leiomyoma: a case report and review of the literature

Related Questions

What is Irma Kerliu-Saliu's role at AbbVie?
How did Irma Kerliu-Saliu contribute to the case report on atypical uterine leiomyoma?
What are the key performance indicators (KPIs) Irma Kerliu-Saliu tracks in her role at AbbVie?
What is the significance of Irma Kerliu-Saliu's work in the field of medical science liaisons?
How does Irma Kerliu-Saliu's background in pharmacy influence her work in medical affairs?
Irma Kerliu-Saliu
Irma Kerliu-Saliu, photo 1
Irma Kerliu-Saliu, photo 2
Add to my network

Location

Greater Boston Area